SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-025196
Filing Date
2020-12-11
Accepted
2020-12-11 16:02:27
Documents
7
Period of Report
2020-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20201211_8k.htm 8-K 37795
2 EXHIBIT 1.1 ex_217207.htm EX-1.1 257728
3 EXHIBIT 3.1 ex_217208.htm EX-3.1 1264
4 EXHIBIT 4.1 ex_217209.htm EX-4.1 106599
5 EXHIBIT 10.1 ex_217210.htm EX-10.1 235647
6 EXHIBIT 99.1 ex_217211.htm EX-99.1 10689
7 a01.jpg GRAPHIC 328814
  Complete submission text file 0001437749-20-025196.txt   1104026
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINSVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 201383595
SIC: 2860 Industrial Organic Chemicals